Abstracts

Submission Period

Opening of the Online Submission Services: 9th may to 5th August 2019

Notifications: 22th August

Step 1 - Abstract Information

Title

Maximum 200 characters typed in lower-case letters.

Topic

Select one topic from the list of topics which best describes the abstract content (for Abstract Evaluation). Make sure you select the appropriate topic as this choice will determine which graders will review your abstract.

Topics:

• Basic/Translational Science
• Cardiovascular Implantable Electronic Devices
• Clinical Electrophysiology and Catheter Ablation
• Electrocardiography/Holter monitoring/Syncope
• Case reports

Step 2 - Abstract author and institutions

Your abstract must list at least 1 author in order to be submitted.

Authors list

The first author should be the abstract presenter by default. Nevertheless, it can be changed through the agreement form process at a later stage. In all cases, the presenter must be part of the author's list included in the submitted abstract. You may enter up to 8 authors in the author's list including the presenter.

The submitter certifies that he has permission from all persons he enters as co-authors to be listed in this abstract and that they are aware that their names will appear in all publications.

The names of authors will be published as listed on the submission form. Please make sure the information given for each author is correct, as no changes will be possible after the abstract is submitted (see paragraph on changes and corrections above).

Step 3 - Abstract content

All abstracts must be submitted (and will be presented) in English.

Abstracts must contain original material neither published nor presented else where prior to LAHRS 2019 (in print or electronically).

The total number of characters allowed for the submission is 2,000. The character count include spaces. As you enter text into the abstract title, a counter deducts characters from the total allowable number of characters.

We recommend you structure your abstract as follows:

• Background/Introduction
• Objectives
• Methods
• Results
• Conclusions

Abstract Picture

Your picture file must meet the following criteria:

Format: JPEG or GIF

Size: less than 1 MB

Measures no larger than 600 pixels(x) x 800 pixels(y)

Please make sure that your picture is readable on the abstract preview (this represents how it will look in all publications). You can only enter one picture, and the title field is optional.

Important: As the grading and selection process is blinded, the title and body text must not contain identifying features, ie information such as:

Names (authors or other)

Names of institute (hospitals, medical schools, clinics...)

Cities

Also not authorized

Use generic drug names. The use of commercial drug names, brands and registered trademarks is strictly prohibited. Drugs should be referred to by the active substance or pharmacological designation

Company names and location

Web sites and email addresses

Please note that any medical research involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association. We remind you that patient’s photo should be avoided and the patient must never be identifiable in your presentation.

Best abstracts will be purposed to Oral exhibition.

Oral Exhibition

10 minutes in total, (7 minutes for your presentation and 3 minutes for its discussion)

Poster

You must hang your poster from Thursday, September 26th  from 8:30 and remove it on Friday, Sepember 27th before 18:30 hrs .

* The presenter of the Oral Comunication must be registered to the congress, before September 15^th

* At Least one of the authors of the Posters must be registered to the congress, before September15^th.